BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29019676)

  • 21. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
    Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
    BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
    Wang XX; Wan RZ; Liu ZP
    Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
    Kalveram B; Schmidtke G; Groettrup M
    J Cell Sci; 2008 Dec; 121(Pt 24):4079-88. PubMed ID: 19033385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The zinc finger of NEMO is a functional ubiquitin-binding domain.
    Cordier F; Grubisha O; Traincard F; Véron M; Delepierre M; Agou F
    J Biol Chem; 2009 Jan; 284(5):2902-2907. PubMed ID: 19033441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.
    Jian W; Wei X; Chen L; Wang Z; Sun Y; Zhu S; Lou H; Yan S; Li X; Zhou J; Zhang B
    Neurosci Lett; 2017 Sep; 658():114-120. PubMed ID: 28823893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
    Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
    Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicomponent Synthesis and Binding Mode of Imidazo[1,2- a]pyridine-Capped Selective HDAC6 Inhibitors.
    Mackwitz MKW; Hamacher A; Osko JD; Held J; Schöler A; Christianson DW; Kassack MU; Hansen FK
    Org Lett; 2018 Jun; 20(11):3255-3258. PubMed ID: 29790770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HDAC6 activity in kidney diseases: a new perspective.
    Ke B; Chen Y; Tu W; Ye T; Fang X; Yang L
    Mol Med; 2018 Jun; 24(1):33. PubMed ID: 30134806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insight into the zinc finger CW domain as a histone modification reader.
    He F; Umehara T; Saito K; Harada T; Watanabe S; Yabuki T; Kigawa T; Takahashi M; Kuwasako K; Tsuda K; Matsuda T; Aoki M; Seki E; Kobayashi N; Güntert P; Yokoyama S; Muto Y
    Structure; 2010 Sep; 18(9):1127-39. PubMed ID: 20826339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes.
    Hook SS; Orian A; Cowley SM; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13425-30. PubMed ID: 12354939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc finger protein binding to DNA: an energy perspective using molecular dynamics simulation and free energy calculations on mutants of both zinc finger domains and their specific DNA bases.
    Hamed MY; Arya G
    J Biomol Struct Dyn; 2016 May; 34(5):919-34. PubMed ID: 26196228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HDAC complex and cytoskeleton.
    Kovacs JJ; Hubbert C; Yao TP
    Novartis Found Symp; 2004; 259():170-7; discussion 178-81, 223-5. PubMed ID: 15171253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins.
    Hard RL; Liu J; Shen J; Zhou P; Pei D
    Biochemistry; 2010 Dec; 49(50):10737-46. PubMed ID: 21090589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mode of ubiquitin recognition by the ubiquitin-binding zinc finger domain of WRNIP1.
    Suzuki N; Rohaim A; Kato R; Dikic I; Wakatsuki S; Kawasaki M
    FEBS J; 2016 Jun; 283(11):2004-17. PubMed ID: 27062441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for ubiquitin recognition by ubiquitin-binding zinc finger of FAAP20.
    Toma A; Takahashi TS; Sato Y; Yamagata A; Goto-Ito S; Nakada S; Fukuto A; Horikoshi Y; Tashiro S; Fukai S
    PLoS One; 2015; 10(3):e0120887. PubMed ID: 25799058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIAS1 interacts with the KRAB zinc finger protein, ZNF133, via zinc finger motifs and regulates its transcriptional activity.
    Lee SJ; Lee JR; Hahn HS; Kim YH; Ahn JH; Bae CD; Yang JM; Hahn MJ
    Exp Mol Med; 2007 Aug; 39(4):450-7. PubMed ID: 17934332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors.
    Goracci L; Deschamps N; Randazzo GM; Petit C; Dos Santos Passos C; Carrupt PA; Simões-Pires C; Nurisso A
    Sci Rep; 2016 Jul; 6():29086. PubMed ID: 27404291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125.
    Bijlmakers MJ; Teixeira JM; Boer R; Mayzel M; Puig-Sàrries P; Karlsson G; Coll M; Pons M; Crosas B
    Sci Rep; 2016 Jul; 6():29232. PubMed ID: 27411375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin and its binding domains.
    Randles L; Walters KJ
    Front Biosci (Landmark Ed); 2012 Jun; 17(6):2140-57. PubMed ID: 22652769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.